Enliven Therapeutics, Inc.
Clinical-stage biopharma developing kinase inhibitors for precision oncology.
ELVN | US
Overview
Corporate Details
- ISIN(s):
- US29337E1029 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 6200 LOOKOUT ROAD, 80301 BOULDER
- Sector:
- Manufacturing
Description
Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company focuses on the discovery and development of small molecule kinase inhibitors for patients with cancer. Its approach is to create potentially best-in-class or first-in-class therapeutics that address unmet medical needs by enhancing efficacy through improved selectivity, combating treatment resistance, addressing brain metastases, and improving safety and patient convenience.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Enliven Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Enliven Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Enliven Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
